RESEARCH - Long-term follow-up data confirm Vioxx substantially increases risk of stroke, heart attack, and death

[Guest guest]

Medical News Today

Article Date: 14 Oct 2008 - 3:00 PDT

Long-Term Follow-Up Data Confirm -2 Inhibitor Rofecoxib

Substantially Increases Risk Of Stroke, Heart Attack, And Death

Long term follow-up data from the APPROVe trial confirms that use of

the -2 inhibitor rofecoxib* substantially increases the risk of

stroke, heart attack and death compared with placebo. These are the

conclusions of an Article published early Online and in an upcoming

edition of The Lancet. The paper was written by Professor A

Baron, Dartmouth Medical School, Lebanon, New Hampshire, USA, Dr

Bresalier, MD Cancer Center, University of Texas, USA,

and Professor Dion Morton, University of Birmingham, UK and

colleagues.

*****************************************

Read the rest of the article here:

http://www.medicalnewstoday.com/articles/125356.php

Not an MD